CORVEL CORP

CRVL

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Deerfield Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Deerfield ManagementNEWFeb 17, 2026

Shares: 27,629Value: $1.9M

Deerfield's $1.9M initiation in Corvel Corp (workers' compensation claims management software) signals confidence in structural tailwinds around healthcare cost containment and workplace injury management efficiency. The entry follows recent margin expansion in Corvel's core business and reflects Deerfield's conviction that regulatory/payer pressure on medical cost inflation will drive sustained demand for claims automation platforms.

More CRVL Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

RDNT1 fund VTR1 fund PHVS1 fund PMVP1 fund ALHC1 fund ATRC1 fund BCRX1 fund NBIX

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: